PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
复制标题
DOI：
--
复制
发表时间：
2018
期刊：
影响因子：
--
通讯作者：
Yu Rao
中科院分区：
文献类型：
--
作者：
Yonghui Sun;Xingwang Zhao;Ning Ding;Hongying Gao;Yue Wu;Yiqing Yang;Meng Zhao;Jinseok Hwang;Yuqin Song;Wanli Liu;Yu Rao
